These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3056808)

  • 1. Hypoglycemic effect of subcutaneously injected biosynthetic human proinsulin in healthy man.
    Pycior M; Kemmer FW; Berger M
    Horm Metab Res Suppl; 1988; 18():22-4. PubMed ID: 3056808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human proinsulin: bioactivity and pharmaco-kinetics after intravenous and subcutaneous administration.
    Schatz H; Ammermann S
    Horm Metab Res Suppl; 1988; 18():1-5. PubMed ID: 3056805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactivity and pharmacokinetics of human proinsulin in comparison to human insulin after intravenous and subcutaneous injection.
    Schatz H; Ammermann S; Laube H; Federlin K
    Horm Metab Res; 1988 Jul; 20(7):445-9. PubMed ID: 3049293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action profile of biosynthetic human proinsulin trials with the BIOSTATOR in metabolically normal subjects.
    Bottermann P; Wahl K; Ermler R; Gray IP; Hales CN
    Horm Metab Res Suppl; 1988; 18():6-11. PubMed ID: 3056813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of hormonal counterregulation during GCIIS-guided hypoglycemia tests using human proinsulin and human insulin (recombinant DNA).
    Müller-Esch G; von der Lühe C; Ball P; Henkel E; Schlüter KJ; Wood WG; Scriba PC
    Horm Metab Res Suppl; 1988; 18():24-33. PubMed ID: 2847967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of biosynthetic human proinsulin on carbohydrate metabolism in non-insulin-dependent diabetes mellitus.
    Glauber HS; Henry RR; Wallace P; Frank BH; Galloway JA; Cohen RM; Olefsky JM
    N Engl J Med; 1987 Feb; 316(8):443-9. PubMed ID: 3543679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthetic human proinsulin, a new therapeutic compound for diabetics? A comparative study of biosynthetic human proinsulin with biosynthetic human insulin.
    Rosak C; Boehm BO; Althoff PH; Schöffling K
    Horm Metab Res Suppl; 1988; 18():16-21. PubMed ID: 3056807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-action profiles of the intermediate-acting insulin analogue des(64,65)-human proinsulin.
    Heinemann L; Heise T; Klepper A; Ampudia J; Bender R; Starke AA
    Diabete Metab; 1995 Dec; 21(6):415-9. PubMed ID: 8593922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of single and combined infusions of human biosynthetic proinsulin and insulin on glucose metabolism and on plasma hormone concentrations in euglycaemic clamp experiments.
    Nauck MA; Stöckmann F; Thiery J; Ebert R; Creutzfeldt W
    Horm Metab Res Suppl; 1988; 18():60-7. PubMed ID: 3056814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the prolonged hypoglycemic effect of human proinsulin in diabetes mellitus.
    Laube H; Pinter W; Federlin K
    Horm Metab Res Suppl; 1988; 18():12-5. PubMed ID: 3056806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of biosynthetic human proinsulin in patients with terminal renal insufficiency.
    Zilker TR; Rebel C; Kopp KF; Wahl K; Ermler R; Heinzel G; Hales CN; Bottermann P
    Horm Metab Res Suppl; 1988; 18():43-8. PubMed ID: 3056810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a two hour proinsulin infusion on the glucose lowering potency of a following insulin injection.
    Hübinger A; Randerath W; Tosetti P; Schlüter KJ; Gries FA
    Horm Metab Res Suppl; 1988; 18():34-7. PubMed ID: 3056809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of a semi-synthetic human insulin preparation (30/70 NPH insulin Organon): comparison with another 30/70 NPH (Actraphane Novo).
    Gin H; Nivet AM; Morlat P; Aubertin J
    Diabete Metab; 1989; 15(5):247-50. PubMed ID: 2698366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of human proinsulin on blood glucose control and metabolic instability in type 1 diabetes mellitus.
    Bock E; Quabbe HJ
    Diabetes Res; 1989 Apr; 10(4):165-9. PubMed ID: 2692943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoglycaemic effect of proinsulin and insulin in intact and eviscerated rats.
    Kramer U; Hartmann H; Creutzfeldt W
    Horm Metab Res Suppl; 1988; 18():56-60. PubMed ID: 3056812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of biosynthetic human proinsulin following intravenous and subcutaneous administration in metabolically healthy volunteers.
    Zilker TR; Gray IP; Hales CN; Wahl K; Ermler R; Lebender A; Heinzel G; Bottermann P
    Horm Metab Res Suppl; 1988; 18():37-43. PubMed ID: 3192159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Action profile of a semisynthetic human isophane zinc insulin compared with customary isophane insulin].
    Gin H; Delafaye C; Morlat P; Aubertin J
    Diabete Metab; 1992; 18(6):445-50. PubMed ID: 1297601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semisynthetic human insulin: biological and pharmacokinetic effects in normal subjects.
    Brogard JM; Paris-Bockel D; Blickle JF; Cohen B; Pinget M; Stahl A
    Int J Clin Pharmacol Ther Toxicol; 1987 May; 25(5):238-43. PubMed ID: 3298081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma glucose, insulin, proinsulin, C-peptide and glucagon before and after a carbohydrate-rich meal in hyperthyroid patients.
    Rovira A; Valdivielso L; Ortega R; Valverde I; Herrera Pombo JL
    Diabete Metab; 1987; 13(4):431-5. PubMed ID: 3315763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application.
    Rosak C; Hofmann U; Paulwitz O
    Diabetes Nutr Metab; 2004 Jun; 17(3):137-42. PubMed ID: 15334790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.